Published pre-clinical research reports that Ipamorelin stimulates growth hormone release without significantly raising cortisol, prolactin or ACTH, which distinguishes it from earlier growth hormone secretagogues studied in the same class
Ravisankar P, Reddy AA, Nagalakshmi B, Koushik OS, Kumar BV, Anvith PS
There are currently almost 500 peptides recognized by the FDA as having therapeutic value to potentially treat various diseases, including [3]: Bone disorders Genetic disorders Cancer Infectious disease Cardiovascular problems Immune system Respiratory disorders Eye disorders Neurodegenerative problems Poor hormonal health Bone disorders Some of the most commonly used GHRH-promoting peptide drug products include tesamorelin, ipamorelin and sermorelin
Vial, vatten och dos r knda Streck mter volym, inte verksamt mne
Secretagogues like Ipamorelin and CJC-1295 offer a middle path